☆ 4.6 Editorial Material

Preventive antibiotics for stroke-associated pneumonia

NATURE REVIEWS NEUROLOGY (2015)

期刊

NATURE REVIEWS NEUROLOGY

卷 11, 期 12, 页码 -

出版社

NATURE PUBLISHING GROUP

DOI: 10.1038/nrneurol.2015.220

关键词

-

类别

Clinical Neurology

向作者/读者索取更多资源

Protocol

Reagent

摘要

Pneumonia impedes recovery from acute stroke and contributes to poor clinical outcomes. Two recent clinical trials demonstrate that antibiotics commonly used to treat stroke-associated pneumonia (SAP) neither reduce the frequency of pneumonia nor improve outcome after stroke when administered in a preventive manner. These findings necessitate fundamental reassessment of our current concepts of SAP.

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Medicine, General & Internal

Factors associated with the appropriate use of ultra-broad spectrum antibiotics, meropenem, for suspected healthcare-associated pneumonia

Nathan Kirsch, Jane Ha, Hee-Taik Kang, Tina Frisch, Ji Won Yoo, Craig Grossman, Neema Oroomchi, Hidenobu Shigemitsu, Chad L. Cross, Mutsumi John Kioka

Summary: In hospitalized patients with suspected healthcare-associated pneumonia, using meropenem as a first-line antibiotic does not significantly affect morbidity and mortality rates of pneumonia patients. Patients admitted from a SNF/LTAC or with a history of positive cultures for MDR/ESBL pathogens are more likely to have positive cultures for MDR/ESBL pathogens during hospitalization.

MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Low triiodothyronine syndrome is associated with stroke-associated pneumonia

Huijun Chen, Minjie Xu, Yezhi Huang, Jincai He, Wenwei Ren

Summary: This study found that low T3 syndrome may be a risk factor for SAP in stroke patients. Patients with low T3 syndrome were more likely to develop SAP and had a higher risk of severe SAP.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2022)

添加到收藏夹

Article Clinical Neurology

Variation of stroke-associated pneumonia in stroke units across England and Wales: A registry-based cohort study

M. A. Lobo Chaves, Matthew Gittins, Benjamin Bray, Andy Vail, Craig J. Smith

Summary: This study described the variation of observed stroke-associated pneumonia in England and Wales among stroke patients, finding that patient baseline characteristics only accounted for 5% of the observed variation. Additional explanations for the observed variation in stroke-associated pneumonia need to be explored to reduce variation in antibiotic use for stroke patients.

INTERNATIONAL JOURNAL OF STROKE (2022)

添加到收藏夹

Article Infectious Diseases

Prevention of non-ventilator-associated hospital-acquired pneumonia in Switzerland: atype 2 hybrid effectiveness- implementation trial

Aline Wolfensberger, Lauren Clack, Stefanie von Felten, Mirjam Faes Hesse, Dirk Saleschus, Marie-Theres Meier, Katharina Kusejko, Roger Kouyos, Leonhard Held, Hugo Sax

Summary: This study aimed to test a prevention intervention for non-ventilator-associated hospital-acquired pneumonia and a multifaceted implementation strategy. The results showed that implementing the prevention intervention significantly reduced the incidence rate of nvHAP.

LANCET INFECTIOUS DISEASES (2023)

添加到收藏夹

Article Geriatrics & Gerontology

Development and validation of a nomogram model for prediction of stroke-associated pneumonia associated with intracerebral hemorrhage

Ying Wang, Yuting Chen, Roumeng Chen, Yuchen Xu, Han Zheng, Jiajun Xu, Jinyang Xia, Yifan Cai, Huiqin Xu, Xinshi Wang

Summary: We aimed to establish risk factors for stroke-associated pneumonia (SAP) following intracerebral hemorrhage (ICH) and developed a prediction model with better predictive performance than previous models. The model included factors such as age, sex, lobar involvement, extension into ventricles, dysphagia, disturbance of consciousness, and total muscle strength of the worse side. The model showed improved calibration, AUROC, reclassification ability, and positive net benefit, making it a promising tool for assessing individual risk of developing SAP in patients with ICH and optimizing decision-making.

BMC GERIATRICS (2023)

添加到收藏夹

Article Geriatrics & Gerontology

The use of anticholinergic medication is associated with an increased risk of stroke-associated pneumonia

Elzbieta Gradek-Kwinta, Agnieszka Slowik, Tomasz Dziedzic

Summary: The study found that the use of anticholinergic medication before stroke is associated with an increased risk of stroke-associated pneumonia (SAP), suggesting that the use of anticholinergic medication may increase the risk of pneumonia after a stroke.

AGING CLINICAL AND EXPERIMENTAL RESEARCH (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

As an inhibitor of norepinephrine release, dexmedetomidine provides no improvement on stroke-associated pneumonia in mice

Miaomiao Zhou, Qiong Luo, Younian Xu

Summary: This study examines the effects of dexmedetomidine on stroke-associated pneumonia (SAP) and finds that it does not alleviate symptoms or reduce the extent of infarction. The mechanism linking decreased CD3(+) T cells and DEX's influence on SAP requires further investigation.

FRONTIERS IN PHARMACOLOGY (2023)

添加到收藏夹

Article Nutrition & Dietetics

Higher Stress Hyperglycemia Ratio Is Associated With a Higher Risk of Stroke-Associated Pneumonia

Jiejie Tao, Zhishan Hu, Feiling Lou, Junxin Wu, Zijing Wu, Shuang Yang, Xiaofang Jiang, Meihao Wang, Qiqi Huang, Wenwei Ren

Summary: This study found a significant association between stress hyperglycemia and stroke-associated pneumonia (SAP) in stroke patients, particularly in those without diabetes.

FRONTIERS IN NUTRITION (2022)

添加到收藏夹

Article Microbiology

Microbiology and Outcomes of Institutionalized Patients With Stroke-Associated Pneumonia: An Observational Cohort Study

Jie Zhao, Lei-qing Li, Ning-xin Zhen, Lin-lin Du, Hui Shan, Yang Yu, Zhao-cai Zhang, Wei Cui, Bao-ping Tian

Summary: This study found that 42.5% of patients developed SAP after stroke, with Gram-negative aerobic bacilli being the predominant organisms. SAP prolongs the duration of MV, ICU and hospital stays, and significantly increases 60-day mortality.

FRONTIERS IN MICROBIOLOGY (2021)

添加到收藏夹

Review Chemistry, Multidisciplinary

Pneumonia Associated with Mechanical Ventilation: Management and Preventive Aspects

Alvaro Astasio-Picado, Francisco Javier Perdones Jimenez, Miriam Lopez-Sanchez, Jesus Jurado-Palomo, Maria del Carmen Zabala-Banos

Summary: This study aims to study and learn about different preventive measures used to reduce the incidence of ventilator-associated pneumonia (VAP), as well as the microorganisms that most frequently cause VAP. The results show the usefulness of various preventive measures against these microorganisms, but further research and training are still required to reduce the incidence and mortality of this pathology.

APPLIED SCIENCES-BASEL (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

The Use of Antibiotics for Ventilator-Associated Pneumonia in the MIMIC-IV Database

Rui Yang, Tao Huang, Longbin Shen, Aozi Feng, Li Li, Shuna Li, Liying Huang, Ningxia He, Wei Huang, Hui Liu, Jun Lyu

Summary: By analyzing the clinical characteristics and commonly used antibiotics of patients with VAP in ICUs, this study aims to provide guidance for the rational use of drugs for these patients.

FRONTIERS IN PHARMACOLOGY (2022)

添加到收藏夹

Article Clinical Neurology

High Fibrinogen to Albumin Ratio: A Novel Marker for Risk of Stroke-Associated Pneumonia?

Gangqiang Lin, Minlei Hu, Jiaying Song, Xueqian Xu, Haiwei Liu, Linan Qiu, Hanyu Zhu, Minjie Xu, Dandan Geng, Lexuan Yang, Guiqian Huang, Jincai He, Zhen Wang

Summary: This study found that a high fibrinogen-to-albumin ratio (FAR) is associated with stroke-associated pneumonia (SAP) in patients with acute ischemic stroke (AIS). The high FAR is an independent potential risk factor for SAP, which can help clinicians identify high-risk patients with SAP after AIS.

FRONTIERS IN NEUROLOGY (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

Novel investigational treatments for ventilator-associated pneumonia and critically ill patients in the intensive care unit

Rachael Cusack, Alexis Garduno, Khalid Elkholy, Ignacio Martin-Loeches

Summary: The prevalence of ventilator-associated pneumonia (VAP) has been highlighted by the Covid-19 pandemic, underscoring the need for new antimicrobial approaches. This narrative review examines novel investigational drugs for VAP in the ICU setting, including monoclonal antibody treatments and phage antibiotic synthesis. The post-antibiotic era is approaching, emphasizing the importance of infection control measures and personalized medicine for severe infections.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2022)

添加到收藏夹

Article Nutrition & Dietetics

Lactic Dehydrogenase to Albumin Ratio Is Associated With the Risk of Stroke-Associated Pneumonia in Patients With Acute Ischemic Stroke

Dan Yan, Qiqi Huang, Caijun Dai, Wenwei Ren, Siyan Chen

Summary: This study found that in patients with acute ischemic stroke (AIS), high LDH and low albumin levels were associated with an increased risk of stroke-associated pneumonia (SAP). The LDH to albumin ratio (LAR) may serve as a potential predictor for the incidence of SAP.

FRONTIERS IN NUTRITION (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Low serum transthyretin levels predict stroke-associated pneumonia

Huihua Qiu, Jiaying Song, Jingjie Hu, Liuyuan Wang, Linan Qiu, Haiwei Liu, Gangqiang Lin, Xiaoqian Luan, Yuntao Liu, Jincai He

Summary: This study found that low transthyretin levels significantly increased the risk of stroke-associated pneumonia and were independently associated with the development of SAP. Patients with SAP had worse clinical outcomes at discharge, and factors such as dysphagia, leukocyte count, and NLR were also found to be associated with SAP.

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2022)

添加到收藏夹

Article Clinical Neurology

Do Stroke Care Processes Modify Clinical Outcomes in Patients with Stroke-Associated Pneumonia? A Registry Cohort Study in England and Wales

Marco Antonio Lobo Chaves, Matthew Gittins, Benjamin Bray, Andy Vail, Craig J. Smith

Summary: This study investigated the impact of stroke-associated pneumonia (SAP) on clinical outcomes, and found that SAP remained associated with worse outcomes even after adjusting for acute stroke care processes and their timing.

CEREBROVASCULAR DISEASES (2023)

添加到收藏夹

Review Clinical Neurology

Role of autoantibody levels as biomarkers in the management of patients with myasthenia gravis: A systematic review and expert appraisal

Andreas Meisel, Fulvio Baggi, Anthony Behin, Amelia Evoli, Anna Kostera-Pruszczyk, Renato Mantegazza, Raul Juntas Morales, Anna Rostedt Punga, Sabrina Sacconi, Michael Schroeter, Jan Verschuuren, Louise Crathorne, Kris Holmes, Maria-Isabel Leite

Summary: This study examined the relationship between autoantibody levels and disease activity in patients with myasthenia gravis (MG). The results indicated a potential positive correlation, which could have clinical implications in guiding treatment decisions. However, due to limited and variable evidence, routine clinical use of autoantibody level testing is not currently recommended.

EUROPEAN JOURNAL OF NEUROLOGY (2023)

添加到收藏夹

Article Clinical Neurology

Clinical characteristics, treatments, outcome, and prognostic factors of severe autoimmune encephalitis in the intensive care unit: Standard treatment and the value of additional plasma cell-depleting escalation therapies for treatment-refractory patients

Lisa Schwarz, Nilufar Akbari, Harald Pruss, Andreas Meisel, Franziska Scheibe

Summary: This retrospective single-center study investigated the clinical characteristics, treatments, prognostic factors, and neurological outcome of patients with severe autoimmune encephalitis (AE) in the intensive care unit (ICU). The findings suggest that treatment-refractory AE patients with neuronal surface antibodies (nsAb) can achieve similarly good outcomes after plasma cell-depleting escalation therapy as patients already responding to standard first- and/or second-line therapies.

EUROPEAN JOURNAL OF NEUROLOGY (2023)

添加到收藏夹

Article Clinical Neurology

Risk and course of COVID-19 in immunosuppressed patients with myasthenia gravis

Frauke Stascheit, Ulrike Grittner, Sarah Hoffmann, Philipp Mergenthaler, Michael Schroeter, Tobias Ruck, Mark Pawlitzki, Franz Blaes, Julia Kaiser, Ulrike Schara, Adela Della-Marina, Andrea Thieme, Tim Hagenacker, Christian Jacobi, Benjamin Berger, Peter P. Urban, Karl Christian Knop, Berthold Schalke, De-Hyung Lee, Petra Kalischewski, Heinz Wiendl, Andreas Meisel

Summary: Current immunosuppressive therapy (IST) increases the severity of COVID-19 in patients with myasthenia gravis, but it does not increase the risk of SARS-CoV-2 infection. Therefore, effective strategies should be implemented to prevent COVID-19 in this high-risk group.

JOURNAL OF NEUROLOGY (2023)

添加到收藏夹

Letter Clinical Neurology

Comment on: Nagaoka, A. et al., Motor end-plate analysis to diagnose immune-mediated myasthenia gravis in seronegative patients. J Neurol Sci, 2022. 443: p. 120494

Sarah Hoffmann, Werner Stenzel, Andreas Meisel

JOURNAL OF THE NEUROLOGICAL SCIENCES (2023)

添加到收藏夹

Article Clinical Neurology

Autoantibody detection by a live cell-based assay in conventionally antibody-tested triple seronegative Myasthenia gravis

Sarah Hoffmann, Patrick Waters, Leslie Jacobson, Markus Schuelke, Werner Stenzel, Tobias Ruck, Sophie Lehnerer, Frauke Stascheit, Corinna Preusse, Andreas Meisel

Summary: Autoantibody testing is essential for autoimmune myasthenia gravis diagnosis, but about 15% of patients still show negative results (seronegative MG). This study examined the prevalence of clustered AChR, MuSK, and LRP4 autoantibodies in a large German cohort of seronegative MG patients using a live cell-based assay. Out of 67 SNMG patients, 4.5% had clustered AChR autoantibodies, with two patients showing binding to both adult and fetal AChR. None of the patients tested positive for MuSK or LRP4 autoantibodies. Clinical characteristics were similar between patients with and without clustered AChR autoantibodies. Comparisons with a national MG registry showed broad similarities among seronegative MG patients in both cohorts.

NEUROMUSCULAR DISORDERS (2023)

添加到收藏夹

Article Medicine, General & Internal

Patient-reported burden of myasthenia gravis: baseline results of the international prospective, observational, longitudinal real-world digital study MyRealWorld-MG

Sarah Dewilde, Glenn Philips, Sandra Paci, Jon Beauchamp, Silvia Chiroli, Casey Quinn, Laura Day, Mark Larkin, Jacqueline Palace, Sonia Berrih-Aknin, Kristl G. Claeys, Srikanth Muppidi, Renato Mantegazza, Francesco Sacca, Andreas Meisel, Guillaume Bassez, Hiroyuki Murai, M. F. Janssen

Summary: This study aims to explore the impact of myasthenia gravis (MG) on health-related quality of life (HRQoL) from the perspective of patients. The results showed that MG significantly affects patients' daily activities, anxiety and depression, fatigue, breathing, and vision. The impact of the disease becomes more severe with increasing disease severity.

BMJ OPEN (2023)

添加到收藏夹

Article Clinical Neurology

Serum neurofilament light chain in myasthenia gravis subgroups: An exploratory cohort and case-Control study

Frauke Stascheit, Annette Aigner, Philipp Mergenthaler, Benjamin Hotter, Sarah Hoffmann, Sophie Lehnerer, Christian Meisel, Andreas Meisel

Summary: This study aimed to evaluate the association between Nfl and neuromuscular destruction and disease severity in MG patients. Serum samples from MG patients and controls were analyzed and compared. The results showed that sNfl levels were higher in MG patients compared to controls, but were not consistently associated with disease severity. Thus, sNfl is not a suitable biomarker for monitoring individual disease progression in MG patients.

FRONTIERS IN NEUROLOGY (2023)

添加到收藏夹

Article Clinical Neurology

Complement activation profiles in anti-acetylcholine receptor positive myasthenia gravis

Frauke Stascheit, Omar Chuquisana, Christian W. Keller, Philip Alexander Ambrose, Sarah Hoffmann, Catharina C. Gross, Sophie Lehnerer, Heinz Wiendl, Nick Willcox, Andreas Meisel, Jan D. Luenemann

Summary: In patients with AChR-Ab(+) MG, there is significantly increased activation of the complement system, which remains present even under standard immunosuppressive therapies but is not evident in patients with MuSK-Abs or seronegative MG. Further exploration of complement inhibition proximal to C5 cleavage is suggested for potential therapeutic benefits in AChR-Ab(+) MG.

EUROPEAN JOURNAL OF NEUROLOGY (2023)

添加到收藏夹

Article Clinical Neurology

Does stroke-associated pneumonia play an important role on risk of in-hospital mortality associated with severe stroke? A four-way decomposition analysis of a national cohort of stroke patients

Matthew Gittins, Marco Antonio Lobo Chaves, Andy Vail, Craig J. Smith

Summary: This study examines the association between severe stroke, stroke-associated pneumonia (SAP), and in-hospital mortality. The results suggest that SAP is associated with a higher mortality rate in severe stroke patients. Prioritizing SAP prevention may significantly improve in-hospital survival in severe stroke patients, with a potential reduction in mortality of up to 43%.

INTERNATIONAL JOURNAL OF STROKE (2023)

添加到收藏夹

Article Clinical Neurology

Long-term efficacy and safety of ravulizumab in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis: results from the phase 3 CHAMPION MG open-label extension

Andreas Meisel, Djillali Annane, Tuan Vu, Renato Mantegazza, Masahisa Katsuno, Rasha Aguzzi, Glen Frick, Laura F. Gault, James Howard Jr

Summary: This study analyzed the interim results of an ongoing open-label extension study to evaluate the long-term treatment effects of ravulizumab in patients with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis. The findings showed that ravulizumab demonstrated sustained efficacy and safety in improving the disease condition of patients.

JOURNAL OF NEUROLOGY (2023)

添加到收藏夹

Article Clinical Neurology

Data lake-driven analytics identify nocturnal non-dipping of heart rate as predictor of unfavorable stroke outcome at discharge

Alexander Nelde, Markus G. Klammer, Christian H. Nolte, Helena Stengl, Michael Kraemer, Regina von Rennenberg, Andreas Meisel, Franziska Scheibe, Matthias Endres, Jan F. Scheitz, Christian Meisel

Summary: This study used data lake-enabled technology to assess post-stroke heart rate and heart rate variability, and found that HR modulation and including HR in machine learning models can improve stroke outcome prediction.

JOURNAL OF NEUROLOGY (2023)

添加到收藏夹

Article Medicine, General & Internal

Patient-reported impact of myasthenia gravis in the real world: findings from a digital observational survey-based study (MyRealWorld MG)

Sonia Berrih-Aknin, Jacqueline Palace, Andreas Meisel, Kristl G. Claeys, Srikanth Muppidi, Francesco Sacca, Fatemeh Amini, Mark Larkin, Casey Quinn, Jon Beauchamp, Glenn Philips, Femke De Ruyck, Joyce Ramirez, Sandra Paci

Summary: This study aims to explore the impact of myasthenia gravis (MG) in the real world from a patient perspective. The study included MG patients from different countries and found that despite current treatments, patients still experience a significant burden.

BMJ OPEN (2023)

添加到收藏夹

Article Medicine, Research & Experimental

Eculizumab treatment alters the proteometabolome beyond the inhibition of complement

Christopher Nelke, Christina B. Schroeter, Frauke Stascheit, Niklas Huntemann, Marc Pawlitzki, Alice Willison, Saskia Raeuber, Nico Melzer, Ute Distler, Stefan Tenzer, Kai Stuehler, Andreas Roos, Andreas Meisel, Sven G. Meuth, Tobias Ruck

Summary: Therapeutic strategies targeting complement have revolutionized the treatment of myasthenia gravis. A combined proteomics and metabolomics approach was used to study a cohort of MG patients treated with eculizumab or azathioprine, as well as treatment-naive patients. Eculizumab was found to modulate the serum proteometabolome, affecting pathways related to oxidative stress, MAP kinase signaling, and lipid metabolism, particularly arachidonic acid signaling.

JCI INSIGHT (2023)

添加到收藏夹

Letter Surgery

Carotid Artery Diameter Correlates with Plaque Volume but not with Degree of Stenosis

Alison Phair, Jonathan Ghosh, Charles McCollum, Craig Smith, Frank Bowling, Steven Rogers

EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY (2023)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.